Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Chronic mucocutaneous candidiasis
MeSH D002178 - chronic mucocutaneous candidiasis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D002908:
Chronic disease
0 Companies
0 Drugs
Success rate
D003881:
Dermatomycoses
0 Companies
0 Drugs
Success rate
D002177:
Candidiasis
30 Companies
7 Drugs
$
Success rate
D002178:
Chronic mucocutaneous candidiasis
89 Companies
10 Drugs
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Teva
Amphotericin b
Amphotericin B
1995-03-31
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/1
Phase 3
100
%
8/8
Approved:
8
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Fluconazole
,
Nystatin
,
Terbinafine
Mayne Group
Itraconazole
Johnson & Johnson
Itraconazole
,
Ketoconazole
GSK
Terbinafine
Novartis
Terbinafine
1
2
3
4
5
6
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use